The Eliava Phage Therapy Center (EPTC) is a world-renowned medical facility specializing in the diagnosis and treatment of bacterial infections using bacteriophage therapy. Founded as part of the Eliava Institute of Bacteriophages, Microbiology, and Virology—established in 1923 by Professor Giorgi Eliava—the center has over a century of expertise in phage therapy. EPTC is recognized for treating antibiotic-resistant infections and is a global leader in the field, attracting patients from around the world who seek solutions for chronic and complex bacterial diseases.

• Internal Medicine

• Pediatrics

• Urology

• Gynecology

• ENT (Ear, Nose, Throat)

• Endocrinology

• Surgery

• Dermatology

• Neurology

• Infectious Diseases

• Gastroenterology

• Cardiology

The center specializes in treating a wide range of bacterial infections, including:

• Skin and soft tissue infections (burns, wounds, abscesses)

• Bone and joint infections (osteomyelitis, infected prostheses)

• Eye infections (conjunctivitis)

• Urinary tract infections (prostatitis, cystitis)

• Respiratory infections (chronic bronchitis, cystic fibrosis)

• ENT infections (sinusitis, otitis)

• Gastrointestinal infections (bacterial gastroenteritis)

• Oral cavity infections (gingivitis, stomatitis)

• Multidisciplinary team of experienced specialists

• Personalized, evidence-based phage therapy protocols

• State-of-the-art diagnostic and laboratory services

• Internationally recognized for innovation and success in treating antibiotic-resistant infections

Vision: To be a global leader in the application of phage therapy, providing innovative solutions to combat antibiotic-resistant infections.

Mission: To deliver high-quality, patient-centered care through the use of bacteriophages, advancing the field of phage therapy and improving patient outcomes worldwide.